HanBio Therapeutics
丹生医药
HanBio Therapeutics
Biotech/Healthcare
HanBio Therapeutics is a biotechnology company focused on researching and developing innovative drugs. Leveraging its deep understanding of disease mechanisms, strong target-selection capabilities, industry-leading antibody discovery expertise, and diversified platforms for engineering antibodies…
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-01-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.